Literature DB >> 30045983

MicroRNA hsa-miR-324-5p Suppresses H5N1 Virus Replication by Targeting the Viral PB1 and Host CUEDC2.

Ashish Kumar1, Akhilesh Kumar1, Harshad Ingle1, Sushil Kumar1, Richa Mishra1, Mahendra Kumar Verma1, Debasis Biswas2, Nachimuthu Senthil Kumar3, Anamika Mishra4, Ashwin Ashok Raut4, Akinori Takaoka5, Himanshu Kumar6,7.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that are crucial posttranscriptional regulators for host mRNAs. Recent studies indicate that miRNAs may modulate host response during RNA virus infection. However, the role of miRNAs in immune response against H5N1 infection is not clearly understood. In this study, we showed that expression of cellular miRNA miR-324-5p was downregulated in A549 cells in response to infection with RNA viruses H5N1, A/PR8/H1N1, and Newcastle disease virus (NDV) and transfection with poly(I·C). We found that miR-324-5p inhibited H5N1 replication by targeting the PB1 viral RNA of H5N1 in host cells. In addition, transcriptome analysis revealed that miR-324-5p enhanced the expression of type I interferon, type III interferon, and interferon-inducible genes (ISGs) by targeting CUEDC2, the negative regulator of the JAK1-STAT3 pathway. Together, these findings highlight that the miR-324-5p plays a crucial role in host defense against H5N1 by targeting viral PB1 and host CUEDC2 to inhibit H5N1 replication.IMPORTANCE Highly pathogenic influenza A virus (HPAIV) continues to pose a pandemic threat globally. From 2003 to 2017, H5N1 HPAIV caused 453 human deaths, giving it a high mortality rate (52.74%). This work shows that miR-324-5p suppresses H5N1 HPAIV replication by directly targeting the viral genome (thereby inhibiting viral gene expression) and cellular CUEDC2 gene, the negative regulator of the interferon pathway (thereby enhancing antiviral genes). Our study enhances the knowledge of the role of microRNAs in the cellular response to viral infection. Also, the study provides help in understanding how the host cells utilize small RNAs in controlling the viral burden.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  antiviral immunity; avian viruses; innate immunity; miRNA; viral RNA polymerase

Mesh:

Substances:

Year:  2018        PMID: 30045983      PMCID: PMC6146810          DOI: 10.1128/JVI.01057-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

Review 2.  Type I interferons in host defense.

Authors:  Daniel B Stetson; Ruslan Medzhitov
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

3.  CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling.

Authors:  Wei-Na Zhang; Li Wang; Qiong Wang; Xue Luo; Di-Feng Fang; Yuan Chen; Xin Pan; Jiang-Hong Man; Qing Xia; Bao-Feng Jin; Wei-Hua Li; Tao Li; Bing Liang; Liang Chen; Wei-Li Gong; Ming Yu; Ai-Ling Li; Tao Zhou; Hui-Yan Li
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

Review 4.  Viral exploitation of host SOCS protein functions.

Authors:  Lisa Nowoslawski Akhtar; Etty N Benveniste
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

5.  Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.

Authors:  Gunter Meister; Markus Landthaler; Agnieszka Patkaniowska; Yair Dorsett; Grace Teng; Thomas Tuschl
Journal:  Mol Cell       Date:  2004-07-23       Impact factor: 17.970

6.  The microRNA miR-485 targets host and influenza virus transcripts to regulate antiviral immunity and restrict viral replication.

Authors:  Harshad Ingle; Sushil Kumar; Ashwin Ashok Raut; Anamika Mishra; Diwakar Dattatraya Kulkarni; Takeshi Kameyama; Akinori Takaoka; Shizuo Akira; Himanshu Kumar
Journal:  Sci Signal       Date:  2015-12-08       Impact factor: 8.192

7.  Dysregulation of the miR-324-5p-CUEDC2 axis leads to macrophage dysfunction and is associated with colon cancer.

Authors:  Yuan Chen; Shao-Xin Wang; Rui Mu; Xue Luo; Zhao-Shan Liu; Bing Liang; Hai-Long Zhuo; Xiao-Peng Hao; Qiong Wang; Di-Feng Fang; Zhao-Fang Bai; Qian-Yi Wang; He-Mei Wang; Bao-Feng Jin; Wei-Li Gong; Tao Zhou; Xue-Min Zhang; Qing Xia; Tao Li
Journal:  Cell Rep       Date:  2014-05-29       Impact factor: 9.423

8.  IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity.

Authors:  S Kumar; H Ingle; S Mishra; R S Mahla; A Kumar; T Kawai; S Akira; A Takaoka; A A Raut; H Kumar
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

9.  SOCS, Inflammation, and Autoimmunity.

Authors:  Akihiko Yoshimura; Mayu Suzuki; Ryota Sakaguchi; Toshikatsu Hanada; Hideo Yasukawa
Journal:  Front Immunol       Date:  2012-03-12       Impact factor: 7.561

Review 10.  Cytosolic sensing of viruses.

Authors:  Delphine Goubau; Safia Deddouche; Caetano Reis e Sousa
Journal:  Immunity       Date:  2013-05-23       Impact factor: 31.745

View more
  19 in total

1.  Swine MicroRNAs ssc-miR-221-3p and ssc-miR-222 Restrict the Cross-Species Infection of Avian Influenza Virus.

Authors:  Jingwei Song; Honglei Sun; Haoran Sun; Zhimin Jiang; Junda Zhu; Chenxi Wang; Weihua Gao; Tong Wang; Juan Pu; Yipeng Sun; Hsiang-Yu Yuan; Jinhua Liu
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

2.  Pentagalloylglucose Inhibits the Replication of Rabies Virus via Mediation of the miR-455/SOCS3/STAT3/IL-6 Pathway.

Authors:  Zhongzhong Tu; Mengxian Xu; Jian Zhang; Ye Feng; Zhuo Hao; Changchun Tu; Yan Liu
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

3.  Enhancing the yield of seasonal influenza viruses through manipulation of microRNAs in Madin-Darby canine kidney cells.

Authors:  Suthat Saengchoowong; Pattaraporn Nimsamer; Kritsada Khongnomnan; Witthaya Poomipak; Kesmanee Praianantathavorn; Somruthai Rattanaburi; Yong Poovorawan; Qibo Zhang; Sunchai Payungporn
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-06

4.  Gga-miR-30c-5p Enhances Apoptosis in Fowl Adenovirus Serotype 4-Infected Leghorn Male Hepatocellular Cells and Facilitates Viral Replication through Myeloid Cell Leukemia-1.

Authors:  Areayi Haiyilati; Linyi Zhou; Jiaxin Li; Wei Li; Li Gao; Hong Cao; Yongqiang Wang; Xiaoqi Li; Shijun J Zheng
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

Review 5.  Interplay between host non-coding RNAs and influenza viruses.

Authors:  Gayan Bamunuarachchi; Samuel Pushparaj; Lin Liu
Journal:  RNA Biol       Date:  2021-01-18       Impact factor: 4.652

Review 6.  The Influence of Host miRNA Binding to RNA Within RNA Viruses on Virus Multiplication.

Authors:  Lin Lei; Anchun Cheng; Mingshu Wang; Renyong Jia
Journal:  Front Cell Infect Microbiol       Date:  2022-04-21       Impact factor: 6.073

7.  Integrated mRNA and miRNA profiling in NIH/3T3 cells in response to bovine papillomavirus E6 gene expression.

Authors:  Feng Pang; Mengmeng Zhang; Guohua Li; Zhenxing Zhang; Haifeng Huang; Baobao Li; Chengqiang Wang; Xiaohong Yang; Yiying Zheng; Qi An; Luyin Zhang; Li Du; Fengyang Wang
Journal:  PeerJ       Date:  2019-08-02       Impact factor: 2.984

8.  Comprehensive analysis of differentially expressed microRNAs and mRNAs in MDBK cells expressing bovine papillomavirus E5 oncogene.

Authors:  Feng Pang; Zhen Chen; Chengqiang Wang; Mengmeng Zhang; Zhenxing Zhang; Xiaohong Yang; Yiying Zheng; Ang Liu; Yiwen Cheng; Jie Chen; Bin Li; Li Du; Fengyang Wang
Journal:  PeerJ       Date:  2019-11-22       Impact factor: 2.984

9.  Particulate matter (PM10) enhances RNA virus infection through modulation of innate immune responses.

Authors:  Richa Mishra; Pandikannan Krishnamoorthy; S Gangamma; Ashwin Ashok Raut; Himanshu Kumar
Journal:  Environ Pollut       Date:  2020-07-13       Impact factor: 8.071

Review 10.  The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.

Authors:  Jiulue Hu; Jelena Stojanović; Saman Yasamineh; Pooneh Yasamineh; Sathish Kumar Karuppannan; Mohammed Junaid Hussain Dowlath; Hamed Serati-Nouri
Journal:  Arch Virol       Date:  2021-07-19       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.